The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/show/NCT01687998




Registration number
NCT01687998
Ethics application status
Date submitted
12/09/2012
Date registered
19/09/2012
Date last updated
8/10/2019

Titles & IDs
Public title
A Study of Evacetrapib in High-Risk Vascular Disease
Scientific title
Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition With Evacetrapib in Patients at a High-Risk for Vascular Outcomes
Secondary ID [1] 0 0
I1V-MC-EIAN
Secondary ID [2] 0 0
11949
Universal Trial Number (UTN)
Trial acronym
ACCELERATE
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Cardiovascular Diseases 0 0
Condition category
Condition code

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - Evacetrapib
Treatment: Drugs - Placebo

Experimental: Evacetrapib - Evacetrapib 130 mg tablet, administered orally once daily for up to 4 years. Participants will also receive standard of care for high-risk vascular disease (HRVD).

Placebo Comparator: Placebo - Placebo, tablet administered orally once daily for up to 4 years. Participants will also receive standard of care for HRVD.


Treatment: Drugs: Evacetrapib
Administered Orally

Treatment: Drugs: Placebo
Administered Orally

Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Number of Participants With Composite Primary Endpoint of Cardiovascular (CV) Death, Myocardial Infarction (MI), Stroke, Coronary Revascularization, or Hospitalization for Unstable Angina (UA) - For component endpoints, the number of participants includes those experiencing fatal events and account for all occurrences regardless of whether or not another component event occurred previously.
Timepoint [1] 0 0
Baseline to Study Completion (Up to 4 years)
Secondary outcome [1] 0 0
Mean Percent Change From Baseline to 3 Months in Low-Density (LDL-C) and High-Density Lipoprotein Cholesterol (HDL-C) Levels
Timepoint [1] 0 0
Baseline, 3 Months
Secondary outcome [2] 0 0
Number of Participants With Composite Endpoint of All-Cause Mortality, MI, Stroke, Coronary Revascularization, or Hospitalization for UA - For component endpoints, the number of participants includes those experiencing fatal events and account for all occurrences regardless of whether or not another component event occurred previously.
Timepoint [2] 0 0
Baseline through End of Study (Up to 4 years)
Secondary outcome [3] 0 0
Number of Participants With Composite Endpoint of CV Death, MI, or Coronary Revascularization - For component endpoints, the number of participants includes those experiencing fatal events and account for all occurrences regardless of whether or not another component event occurred previously.
Timepoint [3] 0 0
Baseline through End of Study (Up to 4 years)
Secondary outcome [4] 0 0
Number of Participants With Composite Endpoint of CV Death, MI, Stroke, or Hospitalization for UA - For component endpoints, the number of participants includes those experiencing fatal events and account for all occurrences regardless of whether or not another component event occurred previously.
Timepoint [4] 0 0
Baseline through End of Study (Up to 4 years)
Secondary outcome [5] 0 0
Number of Participants With Triple Composite Endpoint of CV Death, MI, or Stroke - For component endpoints, the number of participants includes those experiencing fatal events and account for all occurrences regardless of whether or not another component event occurred previously.
Timepoint [5] 0 0
Baseline through End of Study (Up to 4 years)

Eligibility
Key inclusion criteria
- Diagnosis of high risk vascular disease (HRVD) (that is, meet at least one of the
disease diagnostic criteria of: 1)History of acute coronary syndrome (ACS) (that is,
=30 days through 365 days after discharge for ACS) 2)cerebrovascular atherosclerotic
disease 3)peripheral arterial disease 4)diabetes mellitus with documented coronary
artery disease and are clinically stable (as judged by the responsible physician).

- Must be treated with a statin for at least 30 days prior to screening. If not treated
with a statin must have documented statin intolerance, or contraindication to statin

- Have a screening high-density lipoprotein cholesterol (HDL-C) =80 milligram per
deciliter (mg/dL) (=2.1 millimole per liter [mmol/L])

- Have screening triglycerides (TG) =400 mg/dL (=4.5 mmol/L)

- Meet 1 of the following criteria:

- screening low-density lipoprotein cholesterol (LDL-C) no more than 10 mg/dL (0.3
mmol/L) above the target chosen by the investigator (either LDL-C <100 mg/dL
[<2.6 mmol/L] or LDL-C <70 mg/dL [<1.8 mmol/L]), OR

- if LDL-C is greater than target, the participant must be on maximum tolerated
statin dose (for at least 30 days), have documented statin intolerance, or
contraindication to statin
Minimum age
18 Years
Maximum age
No limit
Gender
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- Are currently enrolled in, or discontinued within the last 30 days from, a clinical
trial involving an investigational product or non-approved use of a drug or device, or
concurrently enrolled in any other type of medical research judged not to be
scientifically or medically compatible with this study

- Have previously completed or withdrawn from this study, or withdrawn from any other
study investigating evacetrapib

- Female participants who are known to be pregnant or breastfeeding

- Women of child-bearing potential only, who test positive for pregnancy between
screening and randomization, or who do not agree to use a reliable method of birth
control during the study

- History of transient ischemic attack (TIA) or ischemic stroke <30 days and ACS <30
days

- Any reading of systolic blood pressure =180 millimeter of mercury (mm Hg) or diastolic
blood pressure =110 mm Hg at screening or randomization

- History of hemorrhagic stroke or intracranial hemorrhage

- New York Heart Association class III or IV congestive heart failure

- Serum creatinine >2.2 mg/dL (>194.5 micromole per liter [µmol/L]) at screening

- Clinically active liver disease. Participants are not excluded due to Gilbert's
Syndrome or a history of cholelithiasis/cholecystectomy

- History of malignancy within the preceding 3 years prior to screening

- Known malabsorption syndrome with the exception of lactose intolerance

- Participants with a known history of primary or secondary hyperaldosteronism

- Participants with a history of intolerance/hypersensitivity to cholesterol ester
transfer protein (CETP) inhibitors

- Any clinically significant medical condition that according to the investigator could
interfere with participation in the study

- Participants whose life expectancy is anticipated to be less than 4 years

- Unable or unwilling to comply with study requirements, or deemed by the investigator
to be unfit for the study

- Have a history of drug, alcohol, or substance abuse within the past 6 months, as
assessed by the investigator

- Concurrent or anticipated need for treatment with niacin >250 mg/day or for chronic
administration of drugs on the exclusion list

- Previous exposure to the CETP inhibitors dalcetrapib or evacetrapib within the last 3
months or anacetrapib within the last 12 months

- Any planned coronary angiography or coronary revascularization procedure. If
angiography or revascularization is planned, participants may be screened and enrolled
after all such planned procedures are completed.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint(s)
Statistical methods / analysis

Recruitment
Recruitment status
Terminated
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,TAS,VIC
Recruitment hospital [1] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Camperdown
Recruitment hospital [2] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Wollongong
Recruitment hospital [3] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Herston
Recruitment hospital [4] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Milton
Recruitment hospital [5] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Southport
Recruitment hospital [6] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Woodville
Recruitment hospital [7] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Launceston
Recruitment hospital [8] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Box Hill
Recruitment hospital [9] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Geelong
Recruitment hospital [10] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Heidelberg
Recruitment hospital [11] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Melbourne
Recruitment hospital [12] 0 0
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. - Windsor
Recruitment postcode(s) [1] 0 0
2050 - Camperdown
Recruitment postcode(s) [2] 0 0
2522 - Wollongong
Recruitment postcode(s) [3] 0 0
4029 - Herston
Recruitment postcode(s) [4] 0 0
4064 - Milton
Recruitment postcode(s) [5] 0 0
4215 - Southport
Recruitment postcode(s) [6] 0 0
5011 - Woodville
Recruitment postcode(s) [7] 0 0
7250 - Launceston
Recruitment postcode(s) [8] 0 0
3128 - Box Hill
Recruitment postcode(s) [9] 0 0
3220 - Geelong
Recruitment postcode(s) [10] 0 0
3084 - Heidelberg
Recruitment postcode(s) [11] 0 0
3162 - Melbourne
Recruitment postcode(s) [12] 0 0
3183 - Windsor
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arizona
Country [3] 0 0
United States of America
State/province [3] 0 0
Arkansas
Country [4] 0 0
United States of America
State/province [4] 0 0
California
Country [5] 0 0
United States of America
State/province [5] 0 0
Colorado
Country [6] 0 0
United States of America
State/province [6] 0 0
Connecticut
Country [7] 0 0
United States of America
State/province [7] 0 0
Florida
Country [8] 0 0
United States of America
State/province [8] 0 0
Georgia
Country [9] 0 0
United States of America
State/province [9] 0 0
Illinois
Country [10] 0 0
United States of America
State/province [10] 0 0
Indiana
Country [11] 0 0
United States of America
State/province [11] 0 0
Iowa
Country [12] 0 0
United States of America
State/province [12] 0 0
Kansas
Country [13] 0 0
United States of America
State/province [13] 0 0
Kentucky
Country [14] 0 0
United States of America
State/province [14] 0 0
Louisiana
Country [15] 0 0
United States of America
State/province [15] 0 0
Maine
Country [16] 0 0
United States of America
State/province [16] 0 0
Maryland
Country [17] 0 0
United States of America
State/province [17] 0 0
Massachusetts
Country [18] 0 0
United States of America
State/province [18] 0 0
Michigan
Country [19] 0 0
United States of America
State/province [19] 0 0
Minnesota
Country [20] 0 0
United States of America
State/province [20] 0 0
Missouri
Country [21] 0 0
United States of America
State/province [21] 0 0
Montana
Country [22] 0 0
United States of America
State/province [22] 0 0
Nebraska
Country [23] 0 0
United States of America
State/province [23] 0 0
New Jersey
Country [24] 0 0
United States of America
State/province [24] 0 0
New York
Country [25] 0 0
United States of America
State/province [25] 0 0
North Carolina
Country [26] 0 0
United States of America
State/province [26] 0 0
Ohio
Country [27] 0 0
United States of America
State/province [27] 0 0
Oklahoma
Country [28] 0 0
United States of America
State/province [28] 0 0
Oregon
Country [29] 0 0
United States of America
State/province [29] 0 0
Pennsylvania
Country [30] 0 0
United States of America
State/province [30] 0 0
Rhode Island
Country [31] 0 0
United States of America
State/province [31] 0 0
South Carolina
Country [32] 0 0
United States of America
State/province [32] 0 0
South Dakota
Country [33] 0 0
United States of America
State/province [33] 0 0
Tennessee
Country [34] 0 0
United States of America
State/province [34] 0 0
Texas
Country [35] 0 0
United States of America
State/province [35] 0 0
Utah
Country [36] 0 0
United States of America
State/province [36] 0 0
Virginia
Country [37] 0 0
United States of America
State/province [37] 0 0
Washington
Country [38] 0 0
United States of America
State/province [38] 0 0
West Virginia
Country [39] 0 0
United States of America
State/province [39] 0 0
Wisconsin
Country [40] 0 0
Argentina
State/province [40] 0 0
Belgrano
Country [41] 0 0
Argentina
State/province [41] 0 0
Buenos Aires
Country [42] 0 0
Argentina
State/province [42] 0 0
Coronel Suarez
Country [43] 0 0
Argentina
State/province [43] 0 0
Córdoba
Country [44] 0 0
Argentina
State/province [44] 0 0
San Luis
Country [45] 0 0
Argentina
State/province [45] 0 0
San Miguel De Tucuman
Country [46] 0 0
Austria
State/province [46] 0 0
Feldkirch
Country [47] 0 0
Austria
State/province [47] 0 0
Graz
Country [48] 0 0
Austria
State/province [48] 0 0
Innsbruck
Country [49] 0 0
Austria
State/province [49] 0 0
Vienna
Country [50] 0 0
Belgium
State/province [50] 0 0
Antwerpen
Country [51] 0 0
Belgium
State/province [51] 0 0
Brussels
Country [52] 0 0
Belgium
State/province [52] 0 0
Huy
Country [53] 0 0
Belgium
State/province [53] 0 0
Merksem
Country [54] 0 0
Belgium
State/province [54] 0 0
Tienen
Country [55] 0 0
Brazil
State/province [55] 0 0
Fortaleza
Country [56] 0 0
Brazil
State/province [56] 0 0
Rio De Janeiro
Country [57] 0 0
Brazil
State/province [57] 0 0
São Paulo
Country [58] 0 0
Bulgaria
State/province [58] 0 0
Gabrovo
Country [59] 0 0
Bulgaria
State/province [59] 0 0
Pazardzhik
Country [60] 0 0
Bulgaria
State/province [60] 0 0
Pleven
Country [61] 0 0
Bulgaria
State/province [61] 0 0
Plovdiv
Country [62] 0 0
Bulgaria
State/province [62] 0 0
Smolyan
Country [63] 0 0
Bulgaria
State/province [63] 0 0
Sofia
Country [64] 0 0
Canada
State/province [64] 0 0
British Columbia
Country [65] 0 0
Canada
State/province [65] 0 0
Newfoundland and Labrador
Country [66] 0 0
Canada
State/province [66] 0 0
Ontario
Country [67] 0 0
Canada
State/province [67] 0 0
Quebec
Country [68] 0 0
China
State/province [68] 0 0
Beijing
Country [69] 0 0
China
State/province [69] 0 0
Changsha
Country [70] 0 0
China
State/province [70] 0 0
Guang Zhou
Country [71] 0 0
China
State/province [71] 0 0
Harbin
Country [72] 0 0
China
State/province [72] 0 0
Shanghai
Country [73] 0 0
China
State/province [73] 0 0
Shenyang
Country [74] 0 0
Czechia
State/province [74] 0 0
Cesky Krumlov
Country [75] 0 0
Czechia
State/province [75] 0 0
Hodonin
Country [76] 0 0
Czechia
State/province [76] 0 0
Marianske Lazne
Country [77] 0 0
Czechia
State/province [77] 0 0
Pardubice
Country [78] 0 0
Czechia
State/province [78] 0 0
Pisek
Country [79] 0 0
Czechia
State/province [79] 0 0
Prague
Country [80] 0 0
Czechia
State/province [80] 0 0
Pribram
Country [81] 0 0
Czechia
State/province [81] 0 0
Teplice
Country [82] 0 0
Denmark
State/province [82] 0 0
Aalborg
Country [83] 0 0
Denmark
State/province [83] 0 0
Ballerup
Country [84] 0 0
Denmark
State/province [84] 0 0
Copenhagen
Country [85] 0 0
Denmark
State/province [85] 0 0
Kobenhavn
Country [86] 0 0
Denmark
State/province [86] 0 0
Vejle
Country [87] 0 0
Estonia
State/province [87] 0 0
Tallinn
Country [88] 0 0
Estonia
State/province [88] 0 0
Viljandi
Country [89] 0 0
France
State/province [89] 0 0
Bordeaux
Country [90] 0 0
France
State/province [90] 0 0
Dijon
Country [91] 0 0
France
State/province [91] 0 0
Le Coudray
Country [92] 0 0
France
State/province [92] 0 0
Paris
Country [93] 0 0
France
State/province [93] 0 0
Pessac
Country [94] 0 0
France
State/province [94] 0 0
Strasbourg
Country [95] 0 0
France
State/province [95] 0 0
Toulouse
Country [96] 0 0
Germany
State/province [96] 0 0
Altenburg
Country [97] 0 0
Germany
State/province [97] 0 0
Bad Krozingen
Country [98] 0 0
Germany
State/province [98] 0 0
Berlin
Country [99] 0 0
Germany
State/province [99] 0 0
Bielefeld
Country [100] 0 0
Germany
State/province [100] 0 0
Dortmund
Country [101] 0 0
Germany
State/province [101] 0 0
Dresden
Country [102] 0 0
Germany
State/province [102] 0 0
Frankfurt
Country [103] 0 0
Germany
State/province [103] 0 0
Heidelberg
Country [104] 0 0
Germany
State/province [104] 0 0
Kassel
Country [105] 0 0
Germany
State/province [105] 0 0
Mainz
Country [106] 0 0
Germany
State/province [106] 0 0
Mönchengladbach
Country [107] 0 0
Germany
State/province [107] 0 0
Stuttgart
Country [108] 0 0
Germany
State/province [108] 0 0
Tübingen
Country [109] 0 0
Germany
State/province [109] 0 0
Warendorf
Country [110] 0 0
Germany
State/province [110] 0 0
Wiesbaden
Country [111] 0 0
Hong Kong
State/province [111] 0 0
Central
Country [112] 0 0
Hong Kong
State/province [112] 0 0
Hong Kong
Country [113] 0 0
Hong Kong
State/province [113] 0 0
Shatin
Country [114] 0 0
Hungary
State/province [114] 0 0
Bekescsaba
Country [115] 0 0
Hungary
State/province [115] 0 0
Budapest
Country [116] 0 0
Hungary
State/province [116] 0 0
Debrecen
Country [117] 0 0
Hungary
State/province [117] 0 0
Esztergom
Country [118] 0 0
Hungary
State/province [118] 0 0
Hodmezovasarhely
Country [119] 0 0
Hungary
State/province [119] 0 0
Kalocsa
Country [120] 0 0
Hungary
State/province [120] 0 0
Komarom
Country [121] 0 0
Hungary
State/province [121] 0 0
Oroshaza
Country [122] 0 0
Hungary
State/province [122] 0 0
Szekszard
Country [123] 0 0
Hungary
State/province [123] 0 0
Zalaegerszeg
Country [124] 0 0
Israel
State/province [124] 0 0
Haifa
Country [125] 0 0
Israel
State/province [125] 0 0
Jerusalem
Country [126] 0 0
Israel
State/province [126] 0 0
Nazareth
Country [127] 0 0
Israel
State/province [127] 0 0
Rehovot
Country [128] 0 0
Israel
State/province [128] 0 0
Safed
Country [129] 0 0
Israel
State/province [129] 0 0
Tel Hashomer
Country [130] 0 0
Israel
State/province [130] 0 0
Tel-Aviv
Country [131] 0 0
Italy
State/province [131] 0 0
Bologna
Country [132] 0 0
Italy
State/province [132] 0 0
Castelfranco Veneto
Country [133] 0 0
Italy
State/province [133] 0 0
Chieti Scalo
Country [134] 0 0
Italy
State/province [134] 0 0
Milano
Country [135] 0 0
Italy
State/province [135] 0 0
Napoli
Country [136] 0 0
Italy
State/province [136] 0 0
Novara
Country [137] 0 0
Italy
State/province [137] 0 0
Parma
Country [138] 0 0
Italy
State/province [138] 0 0
Piacenza
Country [139] 0 0
Italy
State/province [139] 0 0
San Daniele Del Friuli
Country [140] 0 0
Italy
State/province [140] 0 0
Sessa Aurunca
Country [141] 0 0
Japan
State/province [141] 0 0
Aichi
Country [142] 0 0
Japan
State/province [142] 0 0
Chiba
Country [143] 0 0
Japan
State/province [143] 0 0
Ehime
Country [144] 0 0
Japan
State/province [144] 0 0
Fukuoka
Country [145] 0 0
Japan
State/province [145] 0 0
Gunma
Country [146] 0 0
Japan
State/province [146] 0 0
Hyogo
Country [147] 0 0
Japan
State/province [147] 0 0
Ibaraki
Country [148] 0 0
Japan
State/province [148] 0 0
Ishikawa
Country [149] 0 0
Japan
State/province [149] 0 0
Kanagawa
Country [150] 0 0
Japan
State/province [150] 0 0
Kumamoto
Country [151] 0 0
Japan
State/province [151] 0 0
Kyoto
Country [152] 0 0
Japan
State/province [152] 0 0
Okinawa
Country [153] 0 0
Japan
State/province [153] 0 0
Osaka
Country [154] 0 0
Japan
State/province [154] 0 0
Saitama
Country [155] 0 0
Japan
State/province [155] 0 0
Shizuoka
Country [156] 0 0
Japan
State/province [156] 0 0
Tokushima
Country [157] 0 0
Japan
State/province [157] 0 0
Tokyo
Country [158] 0 0
Japan
State/province [158] 0 0
Yamaguchi
Country [159] 0 0
Korea, Republic of
State/province [159] 0 0
Anyang
Country [160] 0 0
Korea, Republic of
State/province [160] 0 0
Busan
Country [161] 0 0
Korea, Republic of
State/province [161] 0 0
Chungbuk
Country [162] 0 0
Korea, Republic of
State/province [162] 0 0
Daejeon
Country [163] 0 0
Korea, Republic of
State/province [163] 0 0
Gangwon-Do
Country [164] 0 0
Korea, Republic of
State/province [164] 0 0
Goyang
Country [165] 0 0
Korea, Republic of
State/province [165] 0 0
Gwangju
Country [166] 0 0
Korea, Republic of
State/province [166] 0 0
Seoul
Country [167] 0 0
Lithuania
State/province [167] 0 0
Kaunas
Country [168] 0 0
Lithuania
State/province [168] 0 0
Klaipeda
Country [169] 0 0
Lithuania
State/province [169] 0 0
Vilnius
Country [170] 0 0
Mexico
State/province [170] 0 0
Aguascalientes
Country [171] 0 0
Mexico
State/province [171] 0 0
Chihuahua
Country [172] 0 0
Mexico
State/province [172] 0 0
Cul Sinaloa
Country [173] 0 0
Mexico
State/province [173] 0 0
Guadalajara
Country [174] 0 0
Mexico
State/province [174] 0 0
Huixquilucan
Country [175] 0 0
Mexico
State/province [175] 0 0
Mexico City
Country [176] 0 0
Mexico
State/province [176] 0 0
Queretaro
Country [177] 0 0
Mexico
State/province [177] 0 0
San Luis Potosi
Country [178] 0 0
Mexico
State/province [178] 0 0
Tampico
Country [179] 0 0
Mexico
State/province [179] 0 0
Tijuana
Country [180] 0 0
Netherlands
State/province [180] 0 0
Amersfoort
Country [181] 0 0
Netherlands
State/province [181] 0 0
Amsterdam
Country [182] 0 0
Netherlands
State/province [182] 0 0
Beverwijk
Country [183] 0 0
Netherlands
State/province [183] 0 0
Delft
Country [184] 0 0
Netherlands
State/province [184] 0 0
Den Helder
Country [185] 0 0
Netherlands
State/province [185] 0 0
Deventer
Country [186] 0 0
Netherlands
State/province [186] 0 0
Drachten
Country [187] 0 0
Netherlands
State/province [187] 0 0
Heerlen
Country [188] 0 0
Netherlands
State/province [188] 0 0
Hilversum
Country [189] 0 0
Netherlands
State/province [189] 0 0
Hoogeveen
Country [190] 0 0
Netherlands
State/province [190] 0 0
Hoorn
Country [191] 0 0
Netherlands
State/province [191] 0 0
Leiden
Country [192] 0 0
Netherlands
State/province [192] 0 0
S-Hertogenbosch
Country [193] 0 0
Netherlands
State/province [193] 0 0
Tilburg
Country [194] 0 0
Netherlands
State/province [194] 0 0
Venlo
Country [195] 0 0
Netherlands
State/province [195] 0 0
Waalwijk
Country [196] 0 0
Netherlands
State/province [196] 0 0
Zaandam
Country [197] 0 0
Netherlands
State/province [197] 0 0
Zwijndrecht
Country [198] 0 0
New Zealand
State/province [198] 0 0
Addington
Country [199] 0 0
New Zealand
State/province [199] 0 0
Grafton
Country [200] 0 0
New Zealand
State/province [200] 0 0
Hamilton West
Country [201] 0 0
New Zealand
State/province [201] 0 0
Newtown
Country [202] 0 0
New Zealand
State/province [202] 0 0
Tauranga
Country [203] 0 0
New Zealand
State/province [203] 0 0
Westlake
Country [204] 0 0
Poland
State/province [204] 0 0
Bydgoszcz
Country [205] 0 0
Poland
State/province [205] 0 0
Gdansk
Country [206] 0 0
Poland
State/province [206] 0 0
Katowice
Country [207] 0 0
Poland
State/province [207] 0 0
Krakow
Country [208] 0 0
Poland
State/province [208] 0 0
Kutno
Country [209] 0 0
Poland
State/province [209] 0 0
Lodz
Country [210] 0 0
Poland
State/province [210] 0 0
Olawa
Country [211] 0 0
Poland
State/province [211] 0 0
Pulawy
Country [212] 0 0
Poland
State/province [212] 0 0
Skierniewice
Country [213] 0 0
Poland
State/province [213] 0 0
Sobotka
Country [214] 0 0
Poland
State/province [214] 0 0
Warsaw
Country [215] 0 0
Poland
State/province [215] 0 0
Wroclaw
Country [216] 0 0
Puerto Rico
State/province [216] 0 0
Ponce
Country [217] 0 0
Puerto Rico
State/province [217] 0 0
San Juan
Country [218] 0 0
Puerto Rico
State/province [218] 0 0
Trujillo Alto
Country [219] 0 0
Romania
State/province [219] 0 0
Braila
Country [220] 0 0
Romania
State/province [220] 0 0
Bucharest
Country [221] 0 0
Romania
State/province [221] 0 0
Buzau
Country [222] 0 0
Romania
State/province [222] 0 0
Focsani
Country [223] 0 0
Romania
State/province [223] 0 0
Oradea
Country [224] 0 0
Russian Federation
State/province [224] 0 0
Arkhangelsk
Country [225] 0 0
Russian Federation
State/province [225] 0 0
Kemerovo
Country [226] 0 0
Russian Federation
State/province [226] 0 0
Moscow
Country [227] 0 0
Russian Federation
State/province [227] 0 0
Saint Petersburg
Country [228] 0 0
Russian Federation
State/province [228] 0 0
Smolensk
Country [229] 0 0
Russian Federation
State/province [229] 0 0
Tomsk
Country [230] 0 0
Russian Federation
State/province [230] 0 0
Yaroslavl
Country [231] 0 0
Slovakia
State/province [231] 0 0
Bardejov
Country [232] 0 0
Slovakia
State/province [232] 0 0
Bratislava
Country [233] 0 0
Slovakia
State/province [233] 0 0
Kralovsky Chlmec
Country [234] 0 0
Slovakia
State/province [234] 0 0
Nitra
Country [235] 0 0
Slovakia
State/province [235] 0 0
Presov
Country [236] 0 0
Slovakia
State/province [236] 0 0
Zilina
Country [237] 0 0
South Africa
State/province [237] 0 0
Alberton
Country [238] 0 0
South Africa
State/province [238] 0 0
Bellville
Country [239] 0 0
South Africa
State/province [239] 0 0
Bloemfontein
Country [240] 0 0
South Africa
State/province [240] 0 0
Goodwood
Country [241] 0 0
South Africa
State/province [241] 0 0
Johannesburg
Country [242] 0 0
South Africa
State/province [242] 0 0
Kuilsriver
Country [243] 0 0
South Africa
State/province [243] 0 0
Newlands West
Country [244] 0 0
South Africa
State/province [244] 0 0
Parktown West
Country [245] 0 0
South Africa
State/province [245] 0 0
Worcester
Country [246] 0 0
Spain
State/province [246] 0 0
Ciudad Real
Country [247] 0 0
Spain
State/province [247] 0 0
Cordoba
Country [248] 0 0
Spain
State/province [248] 0 0
L´Hospitalet De Llobregat
Country [249] 0 0
Spain
State/province [249] 0 0
Madrid
Country [250] 0 0
Spain
State/province [250] 0 0
Málaga
Country [251] 0 0
Spain
State/province [251] 0 0
Palma De Mallorca
Country [252] 0 0
Spain
State/province [252] 0 0
Pamplona
Country [253] 0 0
Sweden
State/province [253] 0 0
Lund
Country [254] 0 0
Sweden
State/province [254] 0 0
Malmö
Country [255] 0 0
Sweden
State/province [255] 0 0
Stockholm
Country [256] 0 0
Sweden
State/province [256] 0 0
Östersund
Country [257] 0 0
Switzerland
State/province [257] 0 0
Lugano
Country [258] 0 0
Switzerland
State/province [258] 0 0
Zürich
Country [259] 0 0
Taiwan
State/province [259] 0 0
Kaohsiung City
Country [260] 0 0
Taiwan
State/province [260] 0 0
Kaohsiung
Country [261] 0 0
Taiwan
State/province [261] 0 0
Kuei Shan Hsiang
Country [262] 0 0
Taiwan
State/province [262] 0 0
Taichung City
Country [263] 0 0
Taiwan
State/province [263] 0 0
Taichung
Country [264] 0 0
Taiwan
State/province [264] 0 0
Taipei
Country [265] 0 0
Turkey
State/province [265] 0 0
Ankara
Country [266] 0 0
Turkey
State/province [266] 0 0
Konya
Country [267] 0 0
Ukraine
State/province [267] 0 0
Kyiv
Country [268] 0 0
Ukraine
State/province [268] 0 0
Lutsk
Country [269] 0 0
Ukraine
State/province [269] 0 0
Poltava
Country [270] 0 0
United Kingdom
State/province [270] 0 0
Cornwall
Country [271] 0 0
United Kingdom
State/province [271] 0 0
Hertfordshire
Country [272] 0 0
United Kingdom
State/province [272] 0 0
Herts
Country [273] 0 0
United Kingdom
State/province [273] 0 0
London
Country [274] 0 0
United Kingdom
State/province [274] 0 0
Northants
Country [275] 0 0
United Kingdom
State/province [275] 0 0
West Midlands
Country [276] 0 0
United Kingdom
State/province [276] 0 0
Bath
Country [277] 0 0
United Kingdom
State/province [277] 0 0
Frome

Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Name
Eli Lilly and Company
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
The Cleveland Clinic
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
The purpose of the ACCELERATE study is to evaluate the efficacy and safety of evacetrapib in
participants with high-risk vascular disease (HRVD).
Trial website
https://clinicaltrials.gov/show/NCT01687998
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Address 0 0
Eli Lilly and Company
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Summary results
For IPD and results data, please see https://clinicaltrials.gov/show/NCT01687998